Related Experiment Videos
Eicosanoids and myocardial ischaemia
1Institut für Pharmakologie, Universität Düsseldorf, F. R. G.
Insights
Myocardial ischemia significantly alters eicosanoid generation, impacting heart function and other cells. Targeting these pathways offers potential cardioprotective strategies, though challenges remain in developing selective agents.
Area of Science:
- Cardiovascular Science
- Biochemistry
- Pharmacology
Background:
- Eicosanoids play a crucial role in myocardial function.
- Myocardial ischemia causes significant alterations in eicosanoid generation.
- Eicosanoids influence both the injured myocardium and other cells like platelets and leukocytes.
Purpose of the Study:
- To review the alterations in myocardial eicosanoid generation during ischemia.
- To discuss the actions of eicosanoids on myocardial function under ischemic conditions.
- To explore the potential of modulating eicosanoid pathways for cardioprotection.
Main Methods:
- Review of existing data on myocardial eicosanoid generation and function during ischemia.
- Analysis of the effects of eicosanoids on myocardial cells, platelets, and leukocytes.
- Evaluation of therapeutic strategies targeting eicosanoid pathways.
Main Results:
- Large alterations in myocardial eicosanoid generation occur during ischemia.
- Eicosanoids exert significant effects on myocardial function, both directly and indirectly.
- Selective modification of eicosanoid generation presents challenges but holds potential for cardioprotective agents.
- Antagonism of thromboxane may benefit ischemia but is less critical for reperfusion injury.
- Leukotrienes and other peroxidation products are potentially deleterious, necessitating selective inhibitors.
Conclusions:
- Eicosanoid modulation is a promising avenue for cardioprotection during ischemia.
- Further research is needed to develop selective inhibitors for leukotriene formation and action.
- Targeting specific eicosanoid pathways may lead to novel therapeutic strategies for ischemic heart conditions.
Abstract:
The available data clearly suggest large alterations in myocardial eicosanoid generation during myocardial ischaemia and demonstrate important actions of eicosanoids on myocardial function during ischaemic conditions. These actions include direct effects on the injured myocardium as well as influences on other target cells, such as platelets and leukocytes. Selective modifications of eicosanoid generation, for example by providing exogenous PGI2 or by inhibiting oxygen toxicity are most challenging approaches for the design of new and potentially valuable cardioprotective agents. Antagonism of thromboxane formation and/or action might be of some value in ischaemia but appears to be less important for reperfusion injury. Leukotrienes and other noncyclic fatty acid peroxidation products are another group of potentially deleterious agents and there is a definite need for more selective inhibitors of leukotriene formation and/or action to establish their role in ischaemia.